These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22105618)

  • 41. Effects of hesperidin loaded poly(lactic-co-glycolic acid) scaffolds on growth behavior of costal cartilage cells in vitro and in vivo.
    Cho SA; Cha SR; Park SM; Kim KH; Lee HG; Kim EY; Lee D; Khang G
    J Biomater Sci Polym Ed; 2014; 25(6):625-40. PubMed ID: 24588773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro osteogenic differentiation of human amniotic fluid-derived stem cells on a poly(lactide-co-glycolide) (PLGA)-bladder submucosa matrix (BSM) composite scaffold for bone tissue engineering.
    Kim J; Jeong SY; Ju YM; Yoo JJ; Smith TL; Khang G; Lee SJ; Atala A
    Biomed Mater; 2013 Feb; 8(1):014107. PubMed ID: 23353783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A protein/antibiotic releasing poly(lactic-co-glycolic acid)/lecithin scaffold for bone repair applications.
    Shi X; Wang Y; Ren L; Huang W; Wang DA
    Int J Pharm; 2009 May; 373(1-2):85-92. PubMed ID: 19429292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Osteogenic and antimicrobial nanoparticulate calcium phosphate and poly-(D,L-lactide-co-glycolide) powders for the treatment of osteomyelitis.
    Uskoković V; Hoover C; Vukomanović M; Uskoković DP; Desai TA
    Mater Sci Eng C Mater Biol Appl; 2013 Aug; 33(6):3362-73. PubMed ID: 23706222
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Calcium phosphate/poly(D,L-lactic-co-glycolic acid) composite bone substitute materials: evaluation of temporal degradation and bone ingrowth in a rat critical-sized cranial defect.
    van de Watering FCJ; van den Beucken JJJP; Walboomers XF; Jansen JA
    Clin Oral Implants Res; 2012 Feb; 23(2):151-159. PubMed ID: 21631594
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The influence of osteoblast differentiation stage on bone formation in autogenously implanted cell-based poly(lactide-co-glycolide) and calcium phosphate constructs.
    Beloti MM; Sicchieri LG; de Oliveira PT; Rosa AL
    Tissue Eng Part A; 2012 May; 18(9-10):999-1005. PubMed ID: 22150110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Two-layer membranes of calcium phosphate/collagen/PLGA nanofibres: in vitro biomineralisation and osteogenic differentiation of human mesenchymal stem cells.
    Hild N; Schneider OD; Mohn D; Luechinger NA; Koehler FM; Hofmann S; Vetsch JR; Thimm BW; Müller R; Stark WJ
    Nanoscale; 2011 Feb; 3(2):401-9. PubMed ID: 21060938
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Superior performance of co-cultured mesenchymal stem cells and hepatocytes in poly(lactic acid-glycolic acid) scaffolds for the treatment of acute liver failure.
    Liu M; Yang J; Hu W; Zhang S; Wang Y
    Biomed Mater; 2016 Feb; 11(1):015008. PubMed ID: 26836957
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nanostructured hydroxyapatite/poly(lactic-co-glycolic acid) composite coating for controlling magnesium degradation in simulated body fluid.
    Johnson I; Akari K; Liu H
    Nanotechnology; 2013 Sep; 24(37):375103. PubMed ID: 23975041
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biocompatibility of electrospun halloysite nanotube-doped poly(lactic-co-glycolic acid) composite nanofibers.
    Qi R; Cao X; Shen M; Guo R; Yu J; Shi X
    J Biomater Sci Polym Ed; 2012; 23(1-4):299-313. PubMed ID: 21244744
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the biocompatibility of calcium phosphate cement/PLGA microparticle composites.
    Link DP; van den Dolder J; van den Beucken JJ; Cuijpers VM; Wolke JG; Mikos AG; Jansen JA
    J Biomed Mater Res A; 2008 Dec; 87(3):760-9. PubMed ID: 18200545
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The fabrication of nano-hydroxyapatite on PLGA and PLGA/collagen nanofibrous composite scaffolds and their effects in osteoblastic behavior for bone tissue engineering.
    Ngiam M; Liao S; Patil AJ; Cheng Z; Chan CK; Ramakrishna S
    Bone; 2009 Jul; 45(1):4-16. PubMed ID: 19358900
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of type I collagen on the adhesion, proliferation, and osteoblastic gene expression of bone marrow-derived mesenchymal stem cells.
    Liu G; Hu YY; Zhao JN; Wu SJ; Xiong Z; Lu R
    Chin J Traumatol; 2004 Dec; 7(6):358-62. PubMed ID: 15566693
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fabrication of core-sheath structured fibers for model drug release and tissue engineering by emulsion electrospinning.
    Wei K; Li Y; Mugishima H; Teramoto A; Abe K
    Biotechnol J; 2012 May; 7(5):677-85. PubMed ID: 22125296
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel mesoporous silica-based antibiotic releasing scaffold for bone repair.
    Shi X; Wang Y; Ren L; Zhao N; Gong Y; Wang DA
    Acta Biomater; 2009 Jun; 5(5):1697-707. PubMed ID: 19217361
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polypyrrole coating on poly-(lactide/glycolide)-β-tricalcium phosphate screws enhances new bone formation in rabbits.
    Zhao MD; Björninen M; Cao L; Wang HR; Pelto J; Li XQ; Hyttinen J; Jiang YQ; Kellomäki M; Miettinen S; Sándor GK; Seppänen R; Haimi S; Dong J
    Biomed Mater; 2015 Nov; 10(6):065016. PubMed ID: 26610717
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bio-hybrid silk fibroin/calcium phosphate/PLGA nanocomposite scaffold to control the delivery of vascular endothelial growth factor.
    Farokhi M; Mottaghitalab F; Shokrgozar MA; Ai J; Hadjati J; Azami M
    Mater Sci Eng C Mater Biol Appl; 2014 Feb; 35():401-10. PubMed ID: 24411394
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tuning the degradation rate of calcium phosphate cements by incorporating mixtures of polylactic-co-glycolic acid microspheres and glucono-delta-lactone microparticles.
    Sariibrahimoglu K; An J; van Oirschot BA; Nijhuis AW; Eman RM; Alblas J; Wolke JG; van den Beucken JJ; Leeuwenburgh SC; Jansen JA
    Tissue Eng Part A; 2014 Nov; 20(21-22):2870-82. PubMed ID: 24819744
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Three-dimensional composites manufactured with human mesenchymal cambial layer precursor cells as an alternative for sinus floor augmentation: an in vitro study.
    Turhani D; Watzinger E; Weissenböck M; Yerit K; Cvikl B; Thurnher D; Ewers R
    Clin Oral Implants Res; 2005 Aug; 16(4):417-24. PubMed ID: 16117765
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improved biocompatibility of poly(lactic-co-glycolic acid) orv and poly-L-lactic acid blended with nanoparticulate amorphous calcium phosphate in vascular stent applications.
    Zheng X; Wang Y; Lan Z; Lyu Y; Feng G; Zhang Y; Tagusari S; Kislauskis E; Robich MP; McCarthy S; Sellke FW; Laham R; Jiang X; Gu WW; Wu T
    J Biomed Nanotechnol; 2014 Jun; 10(6):900-10. PubMed ID: 24749387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.